← Назад к работе
Работы, на которые ссылается эта работа
Работ: 31
Работа: Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Hannah Farmer, Nuala McCabe, Christopher J. Lord +11
Статья2005Цитирований: 2ABIPARP inhibitors: Synthetic lethality in the clinic
Christopher J. Lord, Alan Ashworth
Обзорная статья2017Цитирований: 2ABIThe multifaceted roles of PARP1 in DNA repair and chromatin remodelling
Arnab Ray Chaudhuri, André Nussenzweig
Обзорная статья2017Цитирований: 2ABIPoly(ADP-ribose) polymerase inhibition: past, present and future
Обзорная статья2020Цитирований: 2ABIA comprehensive review of anticancer mechanisms of action of Alantolactone
Ghader Babaei, Shiva Gholizadeh‐Ghaleh Aziz, Masoumeh Rajabi Bazl +1
Обзорная статья2021Цитирований: 2ABI